[<sup>89</sup>Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study.

[⁸⁹Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study.

Adams, Human; van de Garde, Ewoudt Mw; van Moorsel, Coline Hm; Vugts, Danielle J; van Dongen, Guus Ams; Grutters, Jan C; Keijsers, Ruth G.

Afiliação

Adams H; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital Nieuwegein, The Netherlands.
van de Garde EM; Department of Nuclear Medicine, Green Heart Hospital The Netherlands.
van Moorsel CH; Department of Clinical Pharmacy, St. Antonius Hospital Nieuwegein, The Netherlands.
Vugts DJ; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital Nieuwegein, The Netherlands.
van Dongen GA; Department of Radiology and Nuclear Medicine, VU University Medical Center Amsterdam, The Netherlands.
Grutters JC; Department of Radiology and Nuclear Medicine, VU University Medical Center Amsterdam, The Netherlands.
Keijsers RG; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital Nieuwegein, The Netherlands.

Am J Nucl Med Mol Imaging ; 9(6): 296-308, 2019.

Article em En | MEDLINE | ID: mdl-31976159